FDA approves a new generic valsartan |
News and Updates
eMediNexus Coverage from: 
FDA approves a new generic valsartan
eMediNexus,  14 March 2019
remove_red_eye 497 Views
#Cardiology #Internal Medicine #Pharmacist

0 Read Comments                

The US Food and Drug Administration (FDA) has approved a new generic of angiotensin II receptor blocker (ARB), Diovan (valsartan). The FDA prioritized the review of this drug application to help relieve the recent shortage of this critical medicine as a result of multiple recalls of generic valsartan products from several manufacturers due to the finding that certain lots of valsartan and other ARB medicines contain nitrosamine impurities.
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!